MBXAX | MBXIX | MBXAX / MBXIX | |
Total Expense Ratio | 2.28 | 2.03 | 112% |
Annual Report Gross Expense Ratio | 2.28 | 2.03 | 112% |
Fund Existence | 9 years | 9 years | - |
Gain YTD | -2.076 | -1.984 | 105% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.05B | 8.05B | 100% |
Annual Yield % from dividends | 1.71 | 1.92 | 89% |
Returns for 1 year | -0.59 | -0.35 | 169% |
Returns for 3 years | 6.09 | 6.92 | 88% |
Returns for 5 years | 51.04 | 52.96 | 96% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSACX | 18.97 | N/A | N/A |
Morgan Stanley Inst Passport ovrs eq I | |||
SBHIX | 22.84 | N/A | N/A |
Saratoga Health & Biotechnology I | |||
GSMYX | 23.03 | N/A | N/A |
Goldman Sachs Small/Mid Cap Growth Instl | |||
JLCFX | 69.60 | N/A | N/A |
JHancock Fundamental Large Cap Core R4 | |||
WSCRX | 33.77 | N/A | N/A |
Allspring Small Company Growth R6 |